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microRnA-mediated gene regulation is important in many physiological processes. Here we 
explore the roles of a microRnA, miR-941, in human evolution. We find that miR-941 emerged 
de novo in the human lineage, between six and one million years ago, from an evolutionarily 
volatile tandem repeat sequence. Its copy-number remains polymorphic in humans and shows 
a trend for decreasing copy-number with migration out of Africa. Emergence of miR-941 was 
accompanied by accelerated loss of miR-941-binding sites, presumably to escape regulation. 
We further show that miR-941 is highly expressed in pluripotent cells, repressed upon 
differentiation and preferentially targets genes in hedgehog- and insulin-signalling pathways, 
thus suggesting roles in cellular differentiation. Human-specific effects of miR-941 regulation 
are detectable in the brain and affect genes involved in neurotransmitter signalling. Taken 
together, these results implicate miR-941 in human evolution, and provide an example of rapid 
regulatory evolution in the human linage. 
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Gene expression changes are thought to be one of the main underlying causes of phenotypic differences between spe-cies, including human-specific features such as language, 
tool-making and much extended lifespan1. Mutations affecting the 
expression or structure of regulatory factors, such as transcription 
factors (TFs) and microRNAs (miRNAs), could result in misregula-
tion of hundreds of genes and thus represent one of the powerful 
potential mechanisms of human expression evolution2. Previous 
studies focusing on TFs have indicated an excess of human-specific 
expression divergence for TFs in the liver3 and the brain4. These 
findings suggest that changes in TF expression might explain some 
of the human-specific gene expression divergence.
More recently, human-specific changes in transcript abundance 
during postnatal brain development were correlated with changes in 
miRNA expression5. This study further demonstrated that changes 
in the expression of transcriptional regulators influencing develop-
mental trajectories of many genes in a synergistic fashion might 
have had a more pronounced effect on human brain development 
than changes affecting expression of single genes. Although the 
relevance of such regulatory changes to the evolution of human 
phenotypes remains to be determined, changes in miRNA expres-
sion might have had a notable role in driving gene expression diver-
gence between human and chimpanzee brains6.
In this study, we investigated the birth of novel miRNAs in 
the human lineage and their potential contribution to human-
specific gene expression divergence. miRNAs are short (20–24 
nucleotide) endogenous single-stranded RNAs involved in post-
transcriptional gene silencing7. In mammals, mature miRNAs 
are processed from stable hairpin structures by Drosha and Dicer 
endonucleases. Mature miRNAs function as part of the RNA-
induced silencing complex (RISC). Base-pairing between a seed 
region in the 5′ of a miRNA and the 3′ UTR of an mRNA guides 
RISC to target transcripts, which are then degraded, destabilized 
or translationally inhibited7. miRNA-mediated gene expres-
sion silencing has previously been shown to be important for a 
variety of physiological and pathological processes, such as devel-
opmental patterning, cancer progression, neuronal functions and 
dysfunctions8.
Importantly, miRNAs are known for their rapid evolutionary 
dynamics, with dozens of novel miRNAs emerged in the genomes of 
individual species of nematode9, flies10. Novel miRNA emergence 
could affect expression of hundreds of genes, thus accelerating 
species-specific gene expression evolution.
Results
Identification of human-specific miRNAs. To identify miRNAs 
specific to the human genome, we searched for orthologs of all 
1,733 annotated mature human miRNAs (miRBase11 version 17) in 
the genomes of 11 species: chimpanzee, gorilla, orangutan, rhesus 
macaque, marmoset, mouse, rat, dog, cow, opossum and chicken. 
To do so, we mapped miRNA precursors to each genome using 
reciprocal BLAST12 or reciprocal LiftOver13. For 1,412 out of 1,426 
annotated human miRNA precursors (99%) there was at least one 
ortholog in at least one species (Supplementary Data 1). We next 
extracted mature miRNA orthologs from the precursor sequence 
alignment made using the Muscle sequence alignment algorithm14. 
On the basis of these data, we identified 10 mature human miRNAs 
with no detectable orthologs in any of the 11 species and 12 mature 
miRNAs with sequence changes in seed region that took place in 
the human lineage after the split with chimpanzee (Supplementary 
Table S1).
Expression pattern of human-specific miRNAs. To estimate func-
tional roles of newly emerged or newly mutated human miRNAs, we 
examined expression levels of these miRNAs in two brain regions, 
the prefrontal cortex and the cerebellum, of humans, chimpanzees 
and rhesus macaques using high-throughput RNA sequencing 
(RNA-seq). In agreement with previous observations in flies10, 
more ancient miRNAs, such as those conserved among mammals, 
tended to have higher expression levels than more recently emerged 
miRNAs, such as primate-specific miRNAs (Fig. 1a,b). Accordingly, 
all but one human-specific miRNA were expressed at extremely 
low levels in the human brain or not expressed at all (Fig. 1a,b). The 
only exception was miR-941. In both brain regions it was expressed 
higher than other human-specific or primate-specific miRNAs. 
Furthermore, miR-941 expression in the brain was comparable 
to the median level of conserved mammalian miRNAs (Fig. 1a,b). 
No miR-941 expression was observed in brains of chimpanzees and 
macaques.
Using published RNA-seq data from 23 tissues and cell lines, 
we further assessed miR-941 expression across human tissues and 
cell lines to obtain information for its tissue specificity. Besides 
the prefrontal cortex and the cerebellum6, miR-941 was expressed 
in liver, prostate, endometrium and six human tonsillar B-cell 
populations15–17, as well as in a wide range of human cell lines18,19 
(Fig. 1c; Supplementary Table S2). Notably, miR-941 expression 
levels were substantially higher in cancer-derived cell lines and 
human embryonic stem cells (hESCs) than in normal tissues or 
differentiated hESCs (embryoid body cells) (Fig. 1c).
Is miR-941 a bona fide miRNA? By conducting northern Blot 
experiments, we confirmed the presence of mature miR-941 in 
human prefrontal cortex, cerebellum and kidney (Fig. 1d, see 
Methods). Further, our analysis of sequence variations in miR-941 
reads indicated reduced heterogeneity of the mature miRNA 5′ ter-
minus—a sequence feature associated with functional miRNA20 
(Fig. 1e). Using RNA-seq data from THP-1 (human acute mono-
cytic leukaemia cell line) nucleus and cytoplasm21, we further found 
that miR-941, like most functional miRNAs, is enriched in the cyto-
plasm (Fig. 1f). Finally, miR-941 was associated with AGO proteins, 
the key components of the RISC complex, in multiple AGO immu-
noprecipitation experiments conducted using various sequencing 
platforms-454, Illumina and SOLiD-in a number of human cell 
lines: hESCs, hNSCs, THP-1 and Jurkat cells22–24 (Supplementary 
Table S2, Fig. 1c,g). Notably, miR-941 was associated with AGO 
proteins at levels compatible to or exceeding those observed for 
conserved functional miRNAs (Fig. 1g). Thus, miR-941 displays all 
features of a functional miRNA.
miR-941 sequence evolution. In humans, miR-941 resides in the 
first intron of the DNAJC5 gene in chr20 q13.33. According to miR-
Base annotation, this region contains three copies of pre-miR-941, 
all capable of forming canonical stable hairpin structures (Fig. 2a). 
Remapping miR-941 precursor sequences to the human reference 
genome, we found not three, but seven copies of putative pre- 
miR-941 (Supplementary Fig. S1). Each of the seven precursor 
copies contained a stable hairpin structure including mature miR-
941 and miR-941-star sequences (Fig. 2b,c). Mature miR-941 and 
miR-941-star sequences complement each other, leaving two- 
nucleotide overhangs—a feature indicative of processing by Drosha 
and Dicer enzymes7 (Fig. 2b). Reads corresponding to miR-941 and 
miR-941-star sequences could be identified in human (Fig. 2c), but 
not in chimpanzee or rhesus macaque RNA-seq data.
In the human and macaque genomes, the miR-941 precursor 
region are composed of tandem repeats displaying greater interspe-
cies than intraspecies variation, indicating rapid locus evolution 
(Supplementary Fig. S2a-e). Correspondingly, almost the entire 
repeat region is lost in the chimpanzee genome (Fig. 2a). One of the 
repeat copies present in the macaque genome differs from the rest and 
more closely resembles the human variant of the tandem repeats. It 
is therefore likely that tandem repeats present in the human genome 
were derived from this repeat variant, which has undergone copy 
number expansion and replaced other repeat variants in the human 
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lineage (Supplementary Fig. S2f). It takes two copies of the human 
version of tandem repeats to form pre-miR-941, with the apex of 
the precursor stem loop structure coinciding with the boundary 
between repeats (Supplementary Fig. S2g). As a consequence, cor-
responding genomic regions in chimpanzees and macaque could 
not form stable miRNA precursor hairpins (Fig. 2a,b). To confirm 
the validity of the reference genome sequences, we amplified and 
sequenced the pre-miR-941 locus in one human, eight chimpanzees 
and six rhesus macaques (Supplementary Table S3). The sequences 
matched the reference genome sequences (Supplementary Fig. S3). 
These results demonstrate that miR-941 precursor sequence has 
evolved in humans, most likely after the human–chimpanzee split, 
through tandem repeat replacement and expansion.
To obtain more precise estimates of the miR-941 precursor 
emergence in the human evolutionary lineage, we examined the 
genome of Denisova—an extinct hominid species that diverged 
from the human lineage approximately one million years ago. 
Although overall genome sequencing coverage was relatively low 
(1.9-fold), we found that the corresponding genomic locus in 
the Denisova genome contains at least two copies of the miR-941 
precursor sequence (Fig. 2a, see Methods). Thus, pre-miR-941 for-
mation, as well as copy-number increase, took place between the 
chimpanzee and the Denisova bifurcations: between six to seven 
million and one million years ago (Fig. 3a).
Interestingly, pre-miR-941 copy number might continue to 
change after human and Denisova split. In the human genome, 
pre-miR-941 is located in a genomic region displaying copy-number 
variation among four contemporary human populations: Yoruba, 
Caucasian, Chinese and Japanese25. This is not unexpected, given 
general instability of genomic regions formed by tandem repeats. 
To examine this further, we amplified and sequenced the pre- 
miR-941 locus in 558 individuals from 38 populations from the 
HGDP-CEPH Human Genome Diversity Cell Line Panel26. We 
found a large degree of variation in pre-miR-941 copy number 
among contemporary humans, ranging from 2 to 11 copies (Fig. 3b). 
This variation was not caused by PCR amplification artifacts, as 
indicated by replicate amplifications from six individuals of African 
descent. Further, both pre-miR-941 copy number and copy-number 
variation differed significantly among populations from different 
geographical regions (Kruskal–Wallis test for copy number differ-
ence, P = 0.000065, Bartlett’s test and Levene’s test for copy number 
variation difference, P < 0.000073). The average pre-miR-941 copy 
number decreased from the west to the east: from eight copies in 
sub-Saharan Africans to six copies in Eastern Asians (Fig. 3c,d). 
miR-941 precursor copy number variation was also significantly 
higher in sub-Saharan Africans compared with ‘out of Africa’ pop-
ulations, with the exception of Oceanians and native Americans 
(Bartlett’s test, P = 0.00064, Levene’s test, P = 0.00078) (Fig. 3e).
Identification of miR-941 target genes. The seed sequence of 
miR-941 differs from seed sequences of other human miRNAs, 
suggesting specific regulatory effects. To identify potential targets 
0
5
10
15
PFC
Lo
g2
 n
or
m
al
ize
d 
ex
pr
es
sio
n
(T
PM
)
Hum
an
-S
Prim
ate
-S
Mam
ma
l-S
hsa
-miR
-94
1
0
5
10
15
CB
Lo
g2
 n
or
m
al
ize
d 
ex
pr
es
sio
n
(T
PM
)
Hum
an
-S
Prim
ate
-S
Mam
ma
l-S
hsa
-miR
-
941
RNU6
mir941
PFC Kidney CB VC
0 20 40 60 80
Normalized expression
(TPM)
PFC
CB
Liver
Endometrium
Prostate
TBCs
Fibroblast
SW480
MB-MDA231
U2OS
DLD2
Hela
A549
143B
MCF7
HEK293
THP-1(AGO1)
THP-1(AGO2)
THP-1(AGO3)
hESCs
hEBs
0
1
2
3
4
5 mir-941
En
ric
hm
en
t r
at
io
miR cytoplasm/nucleus
enrichment
0.0
0.2
0.4
0.6
0.8
mir-941
5′
 
H
et
er
og
en
ity
Tiss
ue Ago
Cell
 line
0
5
10
15
20 mir-941
Lo
g2
 n
or
m
al
ize
d
e
xp
re
ss
io
n 
(T
PM
)
AGO
1
AGO
2
AGO
3
0
5
10
15
20 mir-941
Lo
g2
 n
or
m
al
ize
d
e
xp
re
ss
io
n 
(T
PM
)
AGO
2
AGO
3
a
b
c d
e
g
f
Figure 1 | miR-941 expression features. Expression levels of miR-941 and other human-specific miRnA, primate-specific miRnA and miRnA conserved 
among mammals in the human prefrontal cortex (a) and cerebellum (b). Expression of miR-941 in human tissues (green), human tonsillar B-cell 
populations (TBCs) (purple), human cell lines (orange), AGo co-immunoprecipitations in THP-1 cells (yellow) and human EsC and EB cells (blue) (c). 
miR-941 expression levels were estimated based on RnA-seq data as Transcripts Per million reads (TPm): number of reads mapped to the transcript 
normalized by the number of total mapped reads. northern blot analysis of miR-941 expression in human prefrontal cortex (PFC), kidney, cerebellum (CB) 
and visual cortex (VC). u6 RnA (Rnu6) was used as a loading control (d). sequence heterogeneity of 5′ termini of miR-941 and other human miRnA. 
Lower sequence heterogeneity corresponds to a more defined seed region sequence, characteristic of functional miRnA (e). Cytoplasmic enrichment  
of miR-941 and other human miRnA in THP-1 cells. Enrichment of mature miRnA in the cytoplasm rather than in the nucleus is characteristic of the 
majority of functional miRnA (f). Co-immunoprecipitation with AGo proteins of miR-941 and other human miRnA in THP-1 cells (right panel) and  
Jurkat cells (left panel). Association with AGo proteins, the key components of the RIsC complex, is characteristic of functional miRnA (g).
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and potential functions of miR-941, we transfected three human cell 
lines, 293T, HEK and HSF2, with miR-941 duplex or mock duplex. 
We then measured gene expression changes in each cell line 24 h 
after transfection, using Affymetrix Human Genome U133 Plus 2.0 
microarrays. In all three cell lines, we observed significant overrep-
resentation of gene expression inhibition among miR-941 targets 
predicted by TargetScan27 or other five miRNA target prediction 
algorithms28–32 (Fig. 4a-c; Supplementary Fig. S4 and Supplemen-
tary Table S4). Because of the evolutionary novelty of miR-941, target 
site conservation was not required during the target prediction.
We then classified predicted miR-941 targets downregulated 
after transfection with miR-941 duplex, but not the negative 
control, in all three human cell lines, as experimentally verified 
miR-941 target genes (Supplementary Data 2, see Methods). 
Compared with other genes expressed in the cell lines, experimen-
tally verified miR-941 target genes showed significant enrichment 
in two KEGG pathways: hedgehog-signalling pathway and insu-
lin-signalling pathway (hypergeometric test, Bonferroni corrected 
P < 0.032). Notably, in both pathways, miR-941 targets some of 
the key annotated pathway components, including SMO, SUFU  
a b
c
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Figure 2 | miR-941 sequence evolution. Alignment of the genomic regions containing miR-941 precursors between the human, chimpanzee, rhesus 
macaque (Indian and Chinese) and Denisova genome (a). For the Denisova genome, sequence read coverage is shown. miR-941 precursor locations in  
the human genome are drawn based on the miRBase annotation. secondary structure of transcripts corresponding to the miR-941 precursor sequence 
from the human, Denisova, chimpanzee, rhesus macaque (Indian and Chinese) genomes (b). Locations of the mature miR-941 (red) and miR-941-star 
(blue) sequences in the human precursor sequence and their corresponding locations in the other species’ precursors are shown. RnA-seq read coverage 
of the mature miR-941 (red) and miR-941-star (blue) in human tissues (prefrontal cortex and cerebellum), AGo co-immunoprecipitations experiments 
and human cell lines (c). The complete list of data sets used is listed in supplementary Table s3.
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and GLI1 in the hedgehog-signalling pathway33 and IRS1, 
PPARGC1A and FOXO1 in the insulin-signalling pathway34  
(Fig. 4d,f). To further test whether these experimentally verified 
miR-941 targets represent direct targets of miR-941, immunopre-
cipitation by Ago2 (Ago2-IP) was conducted in the human 293T 
cell line. We then used Affymetrix microarrays to compare concen-
trations of transcripts captured in Ago2-IP in cells overexpressing 
miR-941 and in negative controls. We found that genes containing 
predicted miR-941-binding sites and enriched in Ago2-IP in cells 
overexpressing miR-941, showed significant downregulation in 
miR-941 transfection experiments (Supplementary Fig. S5a and 
Supplementary Data 2). Repeating our analyses based on these 
targets we confirmed significant enrichment of these Genes in 
insulin signalling pathway (hypergeometric test, Bonferroni 
corrected P = 0.041).
Evolution of miRNA-941-guided regulation. The emergence of 
miR-941 in humans might have led to the downregulation of genes 
containing corresponding binding sites in their 3′ UTRs. To test 
this, we examined expression of miR-941 target genes in human, 
chimpanzee and rhesus macaque brains. mRNA expression was 
measured in the prefrontal cortex of five human, five chimpanzee 
and two rhesus macaque adult individuals and in the cerebellum 
of five human, five chimpanzee and one rhesus macaque adult 
individuals using Affymetrix Gene1.0 ST arrays6. Using macaque as 
an out-group, we assigned expression changes to either the human 
or the chimpanzee lineages assuming maximum parsimony. For 
miR-941 target genes verified by miR-941 transfection, we found 
a significant excess of transcriptional inhibition in the human 
but not the chimpanzee lineage (Binomial test, P < 0.004, Fig. 5a; 
Supplementary Table S5 and Supplementary Data 2). The excess 
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Figure 3 | miR-941 sequence copy number variation among human populations. Phylogenetic tree showing miR-941 precursor copy numbers in  
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of transcriptional inhibition in the human linage could also be 
observed using putative direct miR-941 target genes identified 
in Ago2-IP (Supplementary Data 2 and Supplementary Fig. 5b). 
Further, the inhibitory effects of miR-941 in the human brain 
largely overlapped between the two brain regions (binomial test, 
P = 0.0000045). Notably, among the miR-941 target genes showing 
human-specific downregulation in both brain regions is the host 
gene of miR-941, DNAJC5, containing three candidate miR-941-
binding sites in its 3′ UTR.
Taken together, our results demonstrate that miR-941 is highly 
expressed compared with other newly emerged human-specific 
miRNA in the prefrontal cortex and cerebellum, as well as in mul-
tiple human cell lines, and has detectable regulatory effects on gene 
expression in the human brain. Although some of these regulatory 
effects might be beneficial, introduction of a new miRNA into an 
established regulatory network might also result in deleterious 
expression changes. In this case, natural selection would lead to 
rapid elimination either of miRNA-941 itself or of miR-941-binding 
sites responsible for deleterious regulatory effects. As miR-941 was 
not eliminated, we predict that more miR-941-binding sites would 
be lost in the human than in the chimpanzee lineage, as the latter 
was not exposed to miR-941 expression. Using macaque as an out-
group, we indeed found greater loss of predicted miR-941-binding 
sites in human than in chimpanzee. Specifically, eight miR-941-
binding sites were lost in the human lineage and three in the chim-
panzee lineage (Fig. 5b; Supplementary Table S6, see Methods). 
Compared with the predicted loss of binding sites based on all 
annotated miRNAs present in the human, chimpanzee and rhesus 
macaque genomes, this excessive loss of miR-941 sites is not 
expected to occur by chance (P = 0.03, Fig. 5b). In contrast, we 
observed no difference in miR-941-binding site gains between 
human and chimpanzee (P = 0.54, Fig. 5c).
Although these results are based on predicted miRNA-binding 
sites, we set out to test them further using experimentally verified 
targets of miR-941. We transfected two macaque kidney cell lines 
(LLCMK2 and FrhK-4) and one macaque skin fibroblast cell line 
with miR-941 duplex or a mock duplex. We then measured gene 
expression changes in each cell line 24 h after the transfection using 
microarrays. In all three cell lines we observed significant overre-
presentation of gene expression inhibition among miR-941 targets 
predicted by TargetScan (Kolmogorov–Smirnov test, P < 0.000037) 
(Supplementary Fig. S6). Furthermore, for genes containing miR-
941 targets sites in both macaques and humans, there was a sig-
nificant overlap of experimentally verified miR-941 targets between 
human and macaque transfection experiments (binomial test, 
P = 0.0027). Importantly, genes containing predicted miR-941-binding 
sites in rhesus macaque and chimpanzee, but not in human, were 
significantly downregulated in the three macaque cell lines upon 
miR-941 transfection (P = 0.042), but not in the three human cell 
lines (P = 0.46) (Fig. 5d). Furthermore, genes that lost miR-941 target 
sites in the human lineage were significantly overrepresented among 
miR-941 targets experimentally verified in the three macaque cell 
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lines (P = 0.036). Taken together, these results show that miR-941 
emergence and copy number increase in the human lineage indeed 
resulted in accelerated loss of miR-941-binding sites.
miRNA-induced downregulation could be avoided by other 
mechanisms that do not involve binding sites loss, such as competi-
tive binding of RNA-binding proteins preventing target incorpora-
tion into the RISC complex35. To test whether any putative miR-941 
targets might avoid downregulation by such indirect mechanisms, 
we looked for genes showing downregulation in miR-941 transfec-
tion experiments in rhesus macaque cell lines, but not in human 
cell lines. We identified 49 genes that contained miR-941-binding 
sites in both the human and the macaque genomes and showed no 
detectable downregulation after miR-941 transfection in the three 
human cell lines. Out of these 49 genes, 19 were downregulated after 
miR-941 transfection in macaque cell lines. Testing the abundance 
of these 19 genes in Ago2-IP conducted in human cells, we found 
significant under-representation of these transcripts in Ago2-IP 
compared with other predicted miR-941 target genes expressed in 
the brain (Wilcoxon signed-rank test, P = 0.00067) (Supplementary 
Fig. S7). This result indicates that some of the predicted miR-941 
targets might avoid downregulation by escaping incorporation into 
the RISC complex.
Discussion
miRNAs are powerful gene expression regulators targeting most 
human genes36. Accordingly, birth of a novel miRNA might influence 
expression of hundreds of genes. Although some of these gene expres-
sion changes might be beneficial, most would be expected to be del-
eterious, an observation that has been experimentally verified in fly37. 
At the same time, novel miRNAs were shown to emerge at a relatively 
rapid rate, either by appearance of transcribed hairpin structures or 
by mutations in the miRNA seed region10, With one exception found 
in flies10, this limits deleterious effects of their emergence on tran-
scriptome regulation. With time most novel miRNAs disappear, few 
being incorporated into regulatory networks and gradually increasing 
their expression level38. This trend can be also clearly observed in our 
data with one notable exception of miR-941.
Although miR-941 precursor sequence has evolved after sepa-
ration of the human and the chimpanzee lineages that took place 
as recently as 6–7 million years ago, expression level of miR-941 
in the human brain is high and comparable to expression levels of 
functional miRNAs conserved in mammals. We speculate that the 
high miR-941 expression level is at least partially owing to amplifi-
cation of its precursor sequence in the human lineage. The genome 
of Denisova, the extinct human relatives that split from the human 
lineage approximately one million years ago already contained at 
least two copies of miR-941 precursor. Genomes of contemporary 
humans contain 2–11 copies of miR-941 precursor, with an average 
of 8 copies found in sub-Samarian Africa, an average of 7 copies 
in Europe, America, Oceania and most of Asia, and an average of 
6 copies in East Asia. One of the tandem repeats constituting pre-
miR-941 in humans contains a C to G substitution at position 15 
of the mature sequence. Mature miRNA sequences containing this 
mutation could be readily detected in human tissues, cell lines and 
AGO immunoprecipitation experiments, along with the wild-type 
miR-941 sequence, in ~15–85% ratio. This shows that both mutant 
and wild-type versions of pre-miR-941 are expressed in humans and 
indicates that multiple copies of wild-type pre-miR-941 could be 
transcriptionally active. In this study, however, we did not investi-
gate whether pre-miR-941 copy number correlates with expression 
level of miR-941 in human tissues or cell lines.
Rapid increase in the expression of a novel miRNA is predicted 
to result in deleterious regulatory effects. In agreement with this 
notion, we observed accelerated loss of miR-941-binding sites in 
the human lineage. Notably, miR-941-binding sites lost in humans 
were targeted by miR-941 transfection into macaque cell lines. 
This confirms that emergence of miR-941 in the human lineage 
would affect expression of genes, which accidentally contain these 
binding sites.
Given the extraordinarily high miR-941 expression in humans, 
it is appealing to speculate that beneficial effects of miR-941 emer-
gence offset deleterious ones. miR-941 transfection into human cell 
lines preferentially affected genes in two pathways: hedgehog sig-
nalling and insulin signalling. Notably, in both pathways, miR-941 
targeted some of the key components (Fig. 4d,f). The hedgehog- 
signaling pathway has a central role in embryonic development and 
is involved in the maintenance of stem cell populations in adults33. 
Abnormal activation of this pathway was further observed in certain 
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forms of cancer33. It is, therefore of interest that miR-941 expres-
sion was highest in hESCs and in many cancer-derived human cell 
lines, and decreased upon stem cell differentiation. Humans dis-
play both increased longevity and increased occurrence of certain 
forms of cancer compared with both chimpanzees and macaques39. 
It is, therefore, appealing to speculate that emergence of miR-941 
enhanced the maintenance of adult stem cell populations, thus sup-
porting longer human lifespan, but rendering human cells more 
prone to malignant transformation. The role of miR-941 in the reg-
ulation of insulin signaling adds support to this notion. The insulin-
signaling pathway was consistently implicated in lifespan regulation 
in many species, including humans. Notably, experimentally veri-
fied targets of miR-941 within this pathway include genes directly 
shown to be involved in lifespan extension in model organisms: 
IRS1, PPARGC1A and FOXO1 (ref. 40). Furthermore, FOXO1 was 
linked to extended human longevity41.
Previous studies have shown that intronic miRNAs are usually 
transcribed along with their host genes and could exert synergis-
tic and antagonistic regulatory effects on their host genes42. It is, 
therefore, notable that the host gene of miR-941, DNAJC5, shows 
human-specific downregulation in both brain regions. DNAJC5 
encodes cysteine-string protein-α (CSPα). CSPα resides in presyn-
aptic terminals, clathrin-coated vesicles and neuroendocrine secre-
tory granules and is involved in neurotransmitter release43–45 and 
is mainly expressed in neurons, rather than glia46–49. Deletion of 
CSPα in flies and mice impairs synaptic function and results in 
neurodegeneration, behavioural deficits and premature death45,50. 
Furthermore, CSPα has been linked to Huntington’s and Parkinson’s 
disease, as well as adult neuronal neroid-lipofuscinosis, a common 
inherited neurodegenerative disease45,51,52. By querying a pro-
tein–protein interaction database, seven genes show direct inter-
action with CSPα. Two out of these seven genes, PRKACA and 
RAB3A, are among the experimentally verified miR-941 targets 
showing human-specific downregulation in brain. Similar to CSPα, 
RAB3A also functions in neurotransmitter release53. Furthermore, 
WDR7, an interaction partner of RAB3A, similarly involved in the 
control of calcium-dependent neurotransmitter release54, is also 
the among experimentally verified miR-941 target genes showing 
human-specific downregulation.
Another hint for the potential involvement of miR-941 and its 
host gene in neuronal functions comes from studies of a microdele-
tion in chr20 q13.33 chromosomal region containing pre-miR-941. 
Individuals containing this microdeletion display mental retarda-
tion, developmental delay, as well as speech and language defects55. 
Besides the pre-miR-941 cluster, the deleted region usually con-
tains more than 20 protein-coding genes. Still, it remains possible 
that miR-941 might be responsible for or contribute to the disease 
phenotype.
In conclusion, we show that the emergence and rapid expansion 
of miR-941 precursor sequence took place in the human evolution-
ary lineage between six and one million years ago, and was accom-
panied by an exceptional increase in miR-941 expression level. 
The emergence of miR-941 was accompanied by accelerated loss 
of its binding sites, presumably due to deleterious effects of miR-
941-guided regulation. Functionally, miR-941 could be associated 
with hedgehog- and insulin-signaling pathways, and thus poten-
tially has a role in the evolution of human longevity. Furthermore, 
human-specific effects of miR-941 regulation are detectable in the 
human brain and affect genes involved in neurotransmitter signal-
ing. Deletion of the genomic region containing pre-miR-941 results 
in disruption of human-specific cognitive functions including 
language and speech. Taken together, the unusual features of 
miR-941 evolution, as well as its potential association with func-
tions linked to human longevity and cognition, suggest roles of 
miR-941 in the evolution of human-specific phenotypes. More gen-
erally, miR-941 evolution provides an example for rapid emergence 
of a novel post-transcriptional regulator, thus allowing for a rare 
opportunity to study consequences of this process on evolution of a 
regulatory network.
Methods
Ethics statement. Informed consent for the use of human tissues for research was 
obtained in writing from all donors or their next of kin. All non-human primates 
used in this study suffered sudden deaths for reasons other than their participation 
in this study and without any relation to the tissue used. Biomedical Research  
Ethics Committee of Shanghai Institutes for Biological Sciences completed the 
review of the use and care of the animals in the research project (approval ID:  
ER-SIBS-260802P).
Human-specific miRNA identification. Human miRNA annotations were  
downloaded from miRBase11 (version 17). To identify human-specific miRNA,  
orthologs of all annotated human miRNA precursors were detected using reciprocal 
BLAST12 or reciprocal LiftOver13 with default settings and required the length of 
hit sequence to be  > 60% and  < 130% of query sequence in the genomes of 11 spe-
cies: chimpanzee (UCSC genome accession code: panTro3), gorilla (UCSC genome 
accession code: gorGor3), orangutan (UCSC genome accession code: ponAbe2), 
rhesus macaque (UCSC genome accession code: rheMac2), marmoset (UCSC 
genome accession code: calJac3), mouse (UCSC genome accession code: mm9), 
rat (UCSC genome accession code: rn4), dog (UCSC genome accession code: 
canFam2), cow (UCSC genome accession code: bosTau6), opossum (UCSC genome 
accession code: monDom5) and chicken (UCSC genome accession code: galGal3). 
Mature miRNA sequences were further extracted from precursor sequence  
alignment using muscle14 (Supplementary Data 1). The genome sequences of 
human and the other 11 species were downloaded from UCSC13. Human-specific 
miRNA were classified as miRNA with not detectable orthologs in any of the 11 
species or with sequence changes in the seed region that took place on the human 
evolutionary lineage after the split with chimpanzee (Supplementary Table S1).
Expression pattern of miR-941. miR-941 expression across human tissues, cell 
lines and multiple AGO immunoprecipitation experiments were estimated using 
the following published RNA-seq data sets: prefrontal cortex and cerebellum6, 
liver15, endometrium16, six human tonsillar B-cell populations17, human cell 
lines18,19 AGO immunoprecipitation experiments22–24 (Supplementary Table S2).
miRNA 5′ heterogeneity and cytoplasm/nucleus enrichment analysis. miRNA 
5′ heterogeneity was estimated as described elsewhere20. Cytoplasm/nucleus  
enrichment analysis of miR-941 mature sequence was based on the data from 
THP-1 (Human acute monocytic leukaemia cell line) as described in ref.  21.  
More detailed method descriptions were in Supplementary Methods.
miRNA-941 sequence evolution analysis. Number of miR-941 precursors in 
the reference human genome was estimated by mapping annotated miR-941 
precursor sequences to the genome (UCSC genome accession code hg19) using 
BLAST or BLAT. RNA secondary structures of the human miR-941 precursor and 
corresponding regions in the genomes of chimpanzee, Indian and Chinese rhesus 
macaques and Denisova were analysed by RNA-fold56. Genomic locations of miR-
941 mature sequence and miR-941-star sequence were determined by mapping 
RNA-seq reads to the miR-941 precursor sequence. Number of miR-941 precursors 
in Denisova was estimated by mapping publicly available Denisova sequence 
reads to the human reference genome. More detailed method descriptions were 
in Supplementary Methods. To determine miR-941 precursor copy number in 
humans and verify its absence in the chimpanzee and rhesus macaque genomes, 
we amplified and sequenced the miR-941 genomic locus from the genomes of one 
human, eight chimpanzee and six rhesus macaque individuals. Sample and primer 
information used in this analysis is listed in Supplementary Table S3.
miR-941 precursor copy number variation analysis. To determine miR-941 
precursor copy number variation among human populations we amplified and 
sequenced genomic region containing miR-941 precursor sequences in 558 indi-
viduals from 38 populations of the HGDP-CEPH Human Genome Diversity Cell 
Line Panel26 (Supplementary Table S7). More detailed PCR method description 
was in the Supplementary Methods.
miR-941 precursor copy number was estimated by mapping annotated miR-
941 precursor sequences to the amplified and sequenced genomic regions using 
Blat. The miR-941 precursor copy number variation results were robust to use of 
other copy number quantification procedures: merging overlapped precursors or 
counting numbers of tandem repeats constituting miR-941 precursor. miR-941 
precursor copy number difference among populations from different geographical  
regions was tested by Kruskal–Wallis test. miR-941 precursor copy number variant 
difference among populations from different geographical regions and between 
sub-Saharan Africans and ‘out of Africa’ populations were tested by Bartlett’s test 
and Levene’s test. Mozabite population was classified as ‘West Asians’ rather than 
‘Africans’ in the region-based copy number and copy number variation analyses. 
To confirm the robustness of miR-941 precursor copy number estimates among 
humans obtained using PCR, we did repeat PCR amplification followed by 
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sequencing for six individuals from African populations. In all six cases, miR-941 
precursor copy number estimates agreed between the experimental replicates (see 
Supplementary Fig. S8).
miRNA transfection, microarray data analysis and mir-941 target effects. 
miRNA transfection experiments were conducted in six cell lines—two human  
derived kidney cell lines (HEK and 293T), one human skin fibroblast cell line 
(HSF2), two macaque derived kidney cell lines (LLCMK2 and FrhK-4), one 
macaque skin fibroblast cell line—as described previously in ref. 6. R RMA package 
was used to quantify gene expression levels.
Ago2 immunoprecipitation (Ago2-IP) experiments after miR-941 overexpres-
sion were conducted in 293T cell line. Briefly, all transfections were performed 
using human 293T cells cultured in 6-well tissue culture plates. Lipofectamine 
2,000 (Invitrogen) was used for a Synthetic miR-941 or a scrambled oligo  
transfection, at 30 nmol l − 1 each (final concentration) per 1×106 cells per well  
of a six-well plate using DharmaFECT (GE Healthcare). Total 5×106 cells were 
collected and subjected to Ago2 immunoprecipitation (Ago2-IP) using the RNA 
isolation kit Mouse Ago2 (Wako Chemicals) according to the manufacturer’s 
instructions. For a negative control, immunoprecipitation was performed using 
non-immune IgG beads prepared with the antibody immobilization bead kit 
(Wako Chemicals). The IP pull down RNA was used as template for an ‘in vitro’ 
transcription reaction generating biotin-labeled antisense cRNA. The cRNA  
was analysed on Affymetrix Human Genome U133 Plus 2.0 arrays following  
the manufacturer’s instructions. The R RMA package was used to quantify gene 
expression levels.
We used GOstats57 to investigate putative functions of experimentally verified 
target genes of miR-941 in human cell lines based on our transfection results.  
More detailed method descriptions were in the Supplementary Methods.
Affymetrix exon array experiment. Cerebellum mRNA samples from five  
human, five chimpanzee and one rhesus macaque for Affymetrix Human Exon 1.0. 
ST Arrays were prepared following the standard GeneChip Whole Transcript  
(WT) Sense Target Labelling Assay. We processed Exon Array data sets following 
the steps described in ref. 6. mRNA samples from prefrontal cortex were  
downloaded from6.
miRNA-941 northern blot. Northern blot experiments were conducted in  
human prefrontal cortex, cerebellum, visual cortex and kidney. Briefly, 10 ng total 
RNA for each sample was analysed in 15% TBE-Urea pre-cast Gel (Invitrogen). 
RNAs were transferred onto positively charged hybond-N  +  nylon membrane  
(GE Healthcare Life Sciences) by a Semi-Dry Electrophoretic Transfer Cell 
(Bio-Rad). Oligonucleotide probes were 5′-end-labeled with [γ-32P] ATP using 
T4 polynucleotide kinase (NEB). The membranes were probed at 39 °C with the 
hybridization solution (Roche) overnight. The membranes were washed by 2× SSC 
and 0.5% SDS twice at 39 °C. Radioactive signals were quantified using Quantity 
ONE (Bio-Rad). The result shows miR-941 has on average 1.2-fold higher expres-
sion in the CB compared with PFC (Supplementary Table S8). This result is in 
general agreement with RNA-seq measurements.
Evolution of miRNA-941-guided regulation. The approach to calculating  
miR-941 regulation effect on human-specific gene expression changing in  
prefrontal cortex and cerebellum was adopted and modified from6. More  
detailed method descriptions were in the Supplementary Methods.
Species-specific gain/loss of miR-941 target sites was estimated using binding 
site predictions by TargetScan based on human, chimpanzee and rhesus macaque 
3′ UTR sequence alignments. Specifically, 3′ UTR sequence alignments of human, 
chimpanzee and rhesus macaque were extracted from 3′ UTR sequence alignment 
file downloaded from TargetScan website27. Only the alignments with  < 5%  
of the gap sequence in human, chimpanzee and macaque were used for down-
stream analysis. TargetScan was used to predict miR-941 target sites across three 
species. Gain/loss of the target sites on the human and the chimpanzee lineages  
was calculated using rhesus macaque sequence as an outgroup. Human-specific 
gain (HSG) ratio of miR-941 target genes was calculated as the ratio between  
HSG miR-941 target gene number and the total number of target genes gained  
on the human and the chimpanzee lineages. Human-specific loss (HSL) ratio  
was calculated as the ratio between the number of HSL of miR-941 target  
genes and the total number of target genes lost on the human and the  
chimpanzee lineages.
The genes shown interaction with CSPα are queried from STRING database, 
which contains known and redicted rotein interactions58. In total seven genes 
(RAB3A, VAMP2, VAMP7, SYT1, HSPA8, CFTR, PRKACA) were returned  
using experiments and textmining methods plus medium confidence score 
(score  > 0.4) filtering. 
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